Recruiting
Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)
NCT07405164
- Conditions
- Abnormalities, Multiple, Angiomatosis, Cardiovascular Diseases, +11 more
- Locations
-
- Beth Israel Deaconess Medical Center ( Site 0107) Boston, Massachusetts, United States
- Dana-Farber Cancer Institute ( Site 0105) Boston, Massachusetts, United States
- Karmanos Cancer Center ( Site 0108) Detroit, Michigan, United States
- Hospital of the University of Pennsylvania Perelman Center for Advanced Medicine ( Site 0100) Philadelphia, Pennsylvania, United States